Calcium dynamics in the ventricular myocytes of SERCA2 knockout mice: A modeling study.
We describe a simulation study of Ca²(+) dynamics in mice with cardiomyocyte-specific conditional excision of the sarco(endo)plasmic reticulum calcium ATPase (SERCA) gene, using an experimental data-driven biophysically-based modeling framework. Previously, we reported a moderately impaired heart function measured in mice at 4 weeks after SERCA2 gene deletion (knockout (KO)), along with a >95% reduction in the level of SERCA2 protein. We also reported enhanced Ca²(+) flux through the L-type Ca²(+) channels and the Na(+)/Ca²(+) exchanger in ventricular myocytes isolated from these mice, compared to the control Serca2(flox/flox) mice (flox-flox (FF)). In the current study, a mathematical model-based analysis was applied to enable further quantitative investigation into changes in the Ca²(+) handling mechanisms in these KO cardiomyocytes. Model parameterization based on a wide range of experimental measurements showed a 67% reduction in SERCA activity and an over threefold increase in the activity of the Na(+)/Ca²(+) exchanger. The FF and KO models were then validated against experimentally measured [Ca²(+)](i) transients and experimentally estimated sarco(endo)plasmic reticulum (SR) function. Simulation results were in quantitative agreement with experimental measurements, confirming that sustained [Ca²(+)](i) transients could be maintained in the KO cardiomyocytes despite severely impaired SERCA function. In silico analysis shows that diastolic [Ca²(+)](i) rises sharply with progressive reductions in SERCA activity at physiologically relevant pacing frequencies. Furthermore, an analysis of the roles of the compensatory mechanisms revealed that the major combined effect of the compensatory mechanisms is to lower diastolic [Ca²(+)](i). Finally, by using a comprehensive sensitivity analysis of the role of all cellular calcium handling mechanisms, we show that the combination of upregulation of the Na(+)/Ca²(+) exchanger and increased L-type Ca²(+) current is the most effective means to maintain diastolic and systolic calcium levels after loss of SERCA function.
University of Oxford, United Kingdom.
L
L
Li
W E
WE
Louch
S A
SA
Niederer
K B
KB
Andersson
G
G
Christensen
O M
OM
Sejersted
N P
NP
Smith
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D020746:Calcium Channels, L-Type / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000235:genetics / Q000378:metabolism; D054849:Cardiac Electrophysiology / Q000379:methods; D017353:Gene Deletion; D006352:Heart Ventricles / Q000166:cytology; D051379:Mice; D018345:Mice, Knockout; D008955:Models, Cardiovascular; D009200:Myocardial Contraction / Q000502:physiology; D009206:Myocardium / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism*; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics* / Q000378:metabolism*; D019831:Sodium-Calcium Exchanger / Q000235:genetics / Q000378:metabolism*
D020746:Calcium Channels, L-Type; D019831:Sodium-Calcium Exchanger; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; C506947:Atp2a2 protein, mouse; D000252:Calcium-Transporting ATPases; D002118:Calcium
Circ Res. 1993 Jul;73(1):184-92
8508529
Am J Physiol. 1983 Jul;245(1):C1-14
6346892
J Physiol. 2006 Jul 15;574(Pt 2):519-33
16709642
Circulation. 1990 Oct;82(4):1266-78
2205417
J Mol Cell Cardiol. 2009 Aug;47(2):171-3
19460389
Circulation. 2002 Sep 3;106(10):1288-93
12208807
Biophys J. 1994 Oct;67(4):1775-87
7819510
Pflugers Arch. 2001 Apr;442(1):96-100
11374074
Circ Res. 1999 Jul 9;85(1):38-46
10400909
Cardiovasc Res. 2010 Apr 1;86(1):63-71
20019150
Circ Res. 2003 May 2;92(8):912-9
12676814
Am J Physiol. 1997 May;272(5 Pt 2):H2416-24
9176313
Circulation. 1999 Feb 9;99(5):641-8
9950661
J Mol Cell Cardiol. 1998 Oct;30(10):1929-37
9799647
Am Heart J. 1995 Apr;129(4):684-9
7900618
Cardiovasc Res. 1987 Aug;21(8):601-5
3328648
Circ Res. 1987 Jul;61(1):70-6
3608112
Circ Res. 1994 Sep;75(3):434-42
8062417
Am J Physiol. 1995 Jan;268(1 Pt 1):C271-7
7840156
Circulation. 1992 Mar;85(3):1046-55
1311223
Science. 1993 Oct 29;262(5134):740-4
8235594
Biophys J. 1998 Mar;74(3):1149-68
9512016
Circulation. 1995 Dec 1;92(11):3220-8
7586307
J Mol Cell Cardiol. 2009 Aug;47(2):180-7
19328205
Prog Biophys Mol Biol. 2011 Jan;104(1-3):2-21
20303361
Cardiovasc Res. 2007 Jan 1;73(1):92-100
17157829
Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1378-403
15142845
Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1045-63
20656884
Am J Physiol. 1998 Apr;274(4):H1335-47
9575939
J Physiol. 2010 Feb 1;588(Pt 3):465-78
20008467